Contraceptive Pills market information, by drug class (Monophasic, Triphasic and Others) – Forecast to 2022, Globally the market for contraceptive Pills is growing steadily and has a bright future. Globally the market for contraceptive Pills is expected to grow at the rate of about around 2.2% from 2019 to 2022.
Contraceptive pills also widely known as birth control pills have proven to be a useful family planning tool, offering reliable access to birth-rate management. The opportunity to delay pregnancies has been paving the way for many women to pursue higher education and professional careers. It could also open doors for millions of families to control their overhead expenses during the economic slowdown, controlling abortion rate, and contributing to all anti-abortion forces.
There have been various contraceptive methods developed for women such as patches, implants, vaginal rings, injectables. However, when it comes to family planning, contraceptive pills are women’s all-time favourite option for the convenience they offer. As a result, contraceptive pills have been increasingly garnering huge popularity, and consequently, its market gains increasing traction on a global level.
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/2122
According to Market Research Future (MRFR), the global contraceptive pills market is projected to grow steadily at around 2.2% CAGR throughout the forecast period (2016- 2022). The efficacy that contraceptive pills offer in birth controlling and family planning is a key driving force behind the growth of the market. Increasing government initiatives to control the birth rate is playing an important role in the growth of the contraceptives market.
increasing awareness and minimizing the healthcare expenses by curbing number of abortion in US encourage contraceptive use among women. North America contraceptives drug market is expected to grow at a CAGR of 5.9 % during forecasted period.
The demand to control the ever-increasing population, worldwide alongside, the young demographics are changing the dynamics of the market. Teenagers are widely accepting contraceptives to enjoy the pleasure of intimate relationships. Additionally, government initiatives are supporting the market growth, promoting education, and the use of contraceptives for avoiding unwanted births.
On the flip side, the dangerous side effects of contraceptive pills are impeding the growth of the market, colossally. Also, cultural and religious dogmas hamper the growth of contraceptive pills market, especially in developing and under-developed countries. Nevertheless, government initiatives and family planning programs would support the growth of the market over the forecast period.
Players leading the global contraceptive pills market include Lupin Pharmaceuticals, Inc, Allergan, Mankind Pharma, Teva Pharmaceuticals, Piramal Enterprises Ltd, Syzygy Healthcare, V Care Pharma, HLL Life Care, Sopharma AD, and Ferring B V, among others.
Global Contraceptive Pills Market – Competitive Analysis
Highly competitive, the global contraceptive pills market appears to be fragmented characterized by the presence of several well-established players. To gain a substantially large market share, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and technology launch.
Pharma companies involved in the development of contraceptive pills adopt modern manufacturing processes to ensure safety and convenience. Patients safety is of the utmost priority to these contraceptive manufacturers. Hence, they continuously review the safety profile of their products and collaborate with health and regulatory authorities, sharing all relevant information.
They employ continuous improvement strategies to analyze and update products, implementing improvements. They strive to commercialize innovative, patented primary care and specialty pills for which they partner with global organizations with the leading capabilities in research, development, manufacturing, and business services.
Global Contraceptive Pills Market – Segments
The report is segmented into two market dynamics to widen the scope of understanding,
By Drug Class : Combination Pills (Monophasic, Multiphasic pills, and others) and Progestin Only Pills, among others.
By Regions : Europe, North America, APAC, and the Rest-of-the-World (RoW).
Global Contraceptive Pills Market – Regional Analysis
North America dominates the global contraceptive pills market. The largest share of the market attributes to the well-spread awareness among the people and high rates of abortions. Approximately 3 MN women in North America experience unplanned pregnancy, and almost 90 % of the women population uses at least one of the birth-controlling methods.
Therefore, increasing incidences of unplanned pregnancy and the high uptake rate of contraceptive pills. The US accounts for the largest market for contraceptive pills followed by Canada. The North American contraceptives drug market is expected to grow at a CAGR of 5.9 % during the forecasted period.
Europe commands the second-largest share of the global contraceptive pills market. Governmental initiatives to minimize the rate of unwanted pregnancy are driving the growth of the regional market, spreading awareness through appropriate initiatives and programs. Besides, the rising healthcare expenses and increasing use of contraceptives drugs have been fuelling the growth of the market in the region.
The contraceptive pills market is brisk in the Asia Pacific region. Increasing the need for population control and the availability of various cost-effective contraception methods drive the growth of the market in the region. Besides, increasing government initiatives to increase the awareness towards different safe methods for contraception and birth control is a major driving force behind the APAC market.
July 30, 2019 — Lyndra Therapeutics (the US), a leading pharmaceutical product company, announced the receiving of USD 13 MN grant from Bill and Melinda Gates Foundation toward the development of a once-a-month oral contraceptive.
Lyndra is developing a new once-monthly oral combination therapy, that can deliver a continuous dose of estrogen & progestin, the same drugs used in daily combined oral contraceptives. Ultra-long-acting oral medicines will remove the burden of daily pills and improve compliance, health, and quality of life for patients.
Lyndra is collaborating with Routes2Results, a non-profit social and public health research organization and collective to conduct a preclinical evaluation of this unique contraceptive pill. The grant is awarded through the Bill & Melinda Gates Family Planning program, created to provide women in low to middle-income countries with access to high-quality contraceptive information, services, and supplies.
Get More Professional and Technical Industry Insights @ https://www.marketresearchfuture.com/reports/contraceptive-pills-market-2122
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312